{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:12:00Z","timestamp":1790237520445,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005721","name":"Universit\u00e4t Bielefeld","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005721","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Two-thirds of published patients with anti-leucine rich, glioma inactivated 1 (LGI1) encephalitis develop hippocampal sclerosis (HS). It is likely that this contributes to residual cognitive long-term deficits and the risk of epilepsy. Almost all patients harbor anti-LGI1-immunoglobulin G-(IgG-) subclass 4, which is considered a \u201cbenign\u201d, non-destructive subclass. In contrast, neuropathological case studies have suggested that the classical complement cascade may contribute to mediotemporal cell death in patients with LGI1 antibodies. IgG subclasses 1, 2, or 3 are required to initiate this cascade. We hypothesized that patients with these anti-LGI1-IgG1\/2\/3 in addition to IgG4 have a higher risk of developing HS than patients with anti-LGI1-IgG4 alone. We retrospectively assessed all anti-LGI1 encephalitis patients from this center with anti-LGI1-IgG-subclass information and follow-up MRI available. Nine out of 20 patients had developed HS (45%). Volumetric FreeSurfer analysis confirmed the visual HS diagnoses. HS and a lower hippocampal volume were associated with anti-LGI1-IgG1\/2\/3. All six patients with this IgG subclass status developed HS. There was no association with older or younger age at onset, female sex, longer latency from disease onset to start of immunotherapy, less intense immunotherapy, higher serum titers of LGI1 antibodies, LGI1 antibodies in CSF or higher LGI1-specific antibody indices. There was no association between anti-LGI1-IgG1\/2\/3 status and neuropsychological performance, epilepsy, or general neurological performance. This confirms our hypothesis that anti-LGI1-IgG1\/2\/3 in serum puts patients at risk of developing HS. If these findings can be confirmed and clinically corroborated, patients with anti-LGI1-IgG1\/2\/3 might become candidates for anti-complement-directed immunological treatments.<\/jats:p>","DOI":"10.1007\/s00415-024-12594-9","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T08:03:07Z","timestamp":1722931387000},"page":"6325-6335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["LGI1 encephalitis: potentially complement-activating anti-LGI1-IgG subclasses 1\/2\/3 are associated with the development of hippocampal sclerosis"],"prefix":"10.1007","volume":"271","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2225-8654","authenticated-orcid":false,"given":"Christian G.","family":"Bien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2538-0786","authenticated-orcid":false,"given":"Anna","family":"Rada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna I.","family":"Bien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5802-8047","authenticated-orcid":false,"given":"Jan","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8158-7442","authenticated-orcid":false,"given":"Anne","family":"Hagemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9502-0491","authenticated-orcid":false,"given":"Friedrich G.","family":"Woermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"key":"12594_CR1","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","volume":"87","author":"H Ari\u00f1o","year":"2016","unstructured":"Ari\u00f1o H, Armangue T, Petit-Pedrol M, Sabater L, Martinez-Hernandez E, Hara M, Lancaster E, Saiz A, Dalmau J, Graus F (2016) Anti-LGI1-associated cognitive impairment: presentation and long-term outcome. Neurology 87:759\u2013765. https:\/\/doi.org\/10.1212\/WNL.0000000000003009","journal-title":"Neurology"},{"key":"12594_CR2","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/0019-2791(71)90489-7","volume":"8","author":"W Augener","year":"1971","unstructured":"Augener W, Grey HM, Cooper NR, Muller-Eberhard HJ (1971) The reaction of monomeric and aggregated immunoglobulins with C1. Immunochemistry 8:1011\u20131020. https:\/\/doi.org\/10.1016\/0019-2791(71)90489-7","journal-title":"Immunochemistry"},{"key":"12594_CR3","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1007\/s00415-020-09814-3","volume":"267","author":"CG Bien","year":"2020","unstructured":"Bien CG, Bien CI, Dogan Onugoren M, De Simoni D, Eigler V, Haensch C-A, Holtkamp M, Ismail FS, Kurthen M, Melzer N, Mayer K, von Podewils F, Rauschka H, Rossetti AO, Sch\u00e4bitz W-R, Simova O, Witt K, H\u00f6ftberger R, May TW (2020) Routine diagnostics for neural antibodies, clinical correlates, treatment and functional outcome. J Neurol 267:2101\u20132114. https:\/\/doi.org\/10.1007\/s00415-020-09814-3","journal-title":"J Neurol"},{"key":"12594_CR4","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1093\/brain\/aws082","volume":"135","author":"CG Bien","year":"2012","unstructured":"Bien CG, Vincent A, Barnett MH, Becker AJ, Blumcke I, Graus F, Jellinger KA, Reuss DE, Ribalta T, Schlegel J, Sutton I, Lassmann H, Bauer J (2012) Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 135:1622\u20131638. https:\/\/doi.org\/10.1093\/brain\/aws082","journal-title":"Brain"},{"key":"12594_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1084\/jem.168.1.127","volume":"168","author":"CI Bindon","year":"1988","unstructured":"Bindon CI, Hale G, Bruggemann M, Waldmann H (1988) Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q. J Exp Med 168:127\u2013142. https:\/\/doi.org\/10.1084\/jem.168.1.127","journal-title":"J Exp Med"},{"key":"12594_CR6","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/epi.12220","volume":"54","author":"I Bl\u00fcmcke","year":"2013","unstructured":"Bl\u00fcmcke I, Thom M, Aronica E, Armstrong DD, Bartolomei F, Bernasconi A, Bernasconi N, Bien CG, Cendes F, Coras R, Cross JH, Jacques TS, Kahane P, Mathern GW, Miyata H, Mosh\u00e9 SL, Oz B, \u00d6zkara \u00c7, Perucca E, Sisodiya S, Wiebe S, Spreafico R (2013) International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a task force report from the ILAE commission on diagnostic methods. Epilepsia 54:1315\u20131329. https:\/\/doi.org\/10.1111\/epi.12220","journal-title":"Epilepsia"},{"key":"12594_CR7","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/ene.13324","volume":"24","author":"M Celicanin","year":"2017","unstructured":"Celicanin M, Blaabjerg M, Maersk-Moller C, Beniczky S, Marner L, Thomsen C, Bach FW, Kondziella D, Andersen H, Somnier F, Illes Z, Pinborg LH (2017) Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies\u2014a national cohort study. Eur J Neurol 24:999\u20131005. https:\/\/doi.org\/10.1111\/ene.13324","journal-title":"Eur J Neurol"},{"key":"12594_CR8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1080\/1744666x.2022.2082946","volume":"18","author":"MC Dalakas","year":"2022","unstructured":"Dalakas MC (2022) Role of complement, anti-complement therapeutics, and other targeted immunotherapies in myasthenia gravis. Expert Rev Clin Immunol 18:691\u2013701. https:\/\/doi.org\/10.1080\/1744666x.2022.2082946","journal-title":"Expert Rev Clin Immunol"},{"key":"12594_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1001\/jamaneurol.2022.4154","volume":"80","author":"J Dalmau","year":"2023","unstructured":"Dalmau J, Graus F (2023) Autoimmune encephalitis: Misdiagnosis, misconceptions, and how to avoid them. JAMA Neurol 80:12\u201314. https:\/\/doi.org\/10.1001\/jamaneurol.2022.4154","journal-title":"JAMA Neurol"},{"key":"12594_CR10","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.4049\/jimmunol.2300307","volume":"211","author":"T Damelang","year":"2023","unstructured":"Damelang T, de Taeye SW, Rentenaar R, Roya-Kouchaki K, de Boer E, Derksen NIL, van Kessel K, Lissenberg-Thunnissen S, Rooijakkers SHM, Jongerius I, Mebius MM, Schuurman J, Labrijn AF, Vidarsson G, Rispens T (2023) The influence of human IgG subclass and allotype on complement activation. J Immunol 211:1725\u20131735. https:\/\/doi.org\/10.4049\/jimmunol.2300307","journal-title":"J Immunol"},{"key":"12594_CR11","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/ageing\/afl045","volume":"35","author":"EJ Dunstan","year":"2006","unstructured":"Dunstan EJ, Winer JB (2006) Autoimmune limbic encephalitis causing fits, rapidly progressive confusion and hyponatraemia. Age Ageing. 35:536\u2013537. https:\/\/doi.org\/10.1093\/ageing\/afl045","journal-title":"Age Ageing."},{"key":"12594_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1001\/jamaneurol.2016.4226","volume":"74","author":"C Finke","year":"2017","unstructured":"Finke C, Pr\u00fcss H, Heine J, Reuter S, Kopp UA, Wegner F, Then Bergh F, Koch S, Jansen O, M\u00fcnte T, Deuschl G, Ruprecht K, St\u00f6cker W, Wandinger KP, Paul F, Bartsch T (2017) Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies. JAMA Neurol 74:50\u201359. https:\/\/doi.org\/10.1001\/jamaneurol.2016.4226","journal-title":"JAMA Neurol"},{"key":"12594_CR13","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","volume":"62","author":"B Fischl","year":"2012","unstructured":"Fischl B (2012) FreeSurfer Neuroimage 62:774\u2013781. https:\/\/doi.org\/10.1016\/j.neuroimage.2012.01.021","journal-title":"FreeSurfer Neuroimage"},{"key":"12594_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/acn3.561","volume":"5","author":"A Gadoth","year":"2018","unstructured":"Gadoth A, Zekeridou A, Klein CJ, Thoreson CJ, Majed M, Dubey D, Flanagan EP, McKeon A, Jenkins SM, Lennon VA, Pittock SJ (2018) Elevated LGI1-IgG CSF index predicts worse neurological outcome. Ann Clin Transl Neurol 5:646\u2013650. https:\/\/doi.org\/10.1002\/acn3.561","journal-title":"Ann Clin Transl Neurol"},{"key":"12594_CR15","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1212\/WNL.42.3.536","volume":"42","author":"F Graus","year":"1992","unstructured":"Graus F, Vega F, Delattre JY, Bonaventura I, Rene R, Arbaiza D, Tolosa E (1992) Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology 42:536\u2013540. https:\/\/doi.org\/10.1212\/WNL.42.3.536","journal-title":"Neurology"},{"key":"12594_CR16","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1007\/s00415-024-12224-4","volume":"271","author":"P Greguletz","year":"2024","unstructured":"Greguletz P, Pl\u00f6tz M, Baade-B\u00fcttner C, Bien CG, Eisenhut K, Geis C, Handreka R, Klausewitz J, K\u00f6rtvelyessy P, Kovac S, Kraft A, Lewerenz J, Malter M, Nagel M, von Podewils F, Pr\u00fc\u00df H, Rada A, Rau J, Rauer S, R\u00f6\u00dfling R, Seifert-Held T, Siebenbrodt K, S\u00fchs KW, Tauber SC, Thaler F, Wagner J, Wickel J, Leypoldt F, Rittner HL, Sommer C, Villmann C, Doppler K (2024) Different pain phenotypes are associated with anti-Caspr2 autoantibodies. J Neurol 271:2736\u20132744. https:\/\/doi.org\/10.1007\/s00415-024-12224-4","journal-title":"J Neurol"},{"key":"12594_CR17","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1007\/s00415-022-11162-3","volume":"269","author":"D Guery","year":"2022","unstructured":"Guery D, Cousyn L, Navarro V, Picard G, Rogemond V, Bani-Sadr A, Shor N, Joubert B, Mu\u00f1iz-Castrillo S, Honnorat J, Rheims S (2022) Long-term evolution and prognostic factors of epilepsy in limbic encephalitis with LGI1 antibodies. J Neurol 269:5061\u20135069. https:\/\/doi.org\/10.1007\/s00415-022-11162-3","journal-title":"J Neurol"},{"key":"12594_CR18","unstructured":"Helmstaedter C, Lendt M, Lux S (2000) VLMT: Verbaler Lern- und Merkf\u00e4higkeitstest. Testhandbuch. Hogrefe, G\u00f6ttingen."},{"key":"12594_CR19","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/ene.12758","volume":"22","author":"MG Huijbers","year":"2015","unstructured":"Huijbers MG, Querol LA, Niks EH, Plomp JJ, van der Maarel SM, Graus F, Dalmau J, Illa I, Verschuuren JJ (2015) The expanding field of IgG4-mediated neurological autoimmune disorders. Eur J Neurol 22:1151\u20131161. https:\/\/doi.org\/10.1111\/ene.12758","journal-title":"Eur J Neurol"},{"key":"12594_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/ana.23577","volume":"72","author":"SR Irani","year":"2012","unstructured":"Irani SR, Pettingill P, Kleopa KA, Schiza N, Waters P, Mazia C, Zuliani L, Watanabe O, Lang B, Buckley C, Vincent A (2012) Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 72:241\u2013255. https:\/\/doi.org\/10.1002\/ana.23577","journal-title":"Ann Neurol"},{"key":"12594_CR21","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.4049\/jimmunol.114.6.1726","volume":"114","author":"D Isenman","year":"1975","unstructured":"Isenman D, Dorrington K, Painter R (1975) The structure and function of immunoglobulin domains: II. The importance of interchain disulfide bonds and the possible role of molecular flexibility in the interaction between immunoglobulin G and complement. J Immunol 114:1726\u20131729","journal-title":"J Immunol"},{"key":"12594_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/NEN.0000000000000063","volume":"73","author":"A Klang","year":"2014","unstructured":"Klang A, Schmidt P, Kneissl S, Bago Z, Vincent A, Lang B, Moloney T, Bien CG, Halasz P, Bauer J, Pakozdy A (2014) IgG and complement deposition and neuronal loss in cats and humans with epilepsy and voltage-gated potassium channel complex antibodies. J Neuropathol Exp Neurol 73:403\u2013413. https:\/\/doi.org\/10.1097\/NEN.0000000000000063","journal-title":"J Neuropathol Exp Neurol"},{"key":"12594_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fimmu.2018.00097","volume":"9","author":"I Koneczny","year":"2018","unstructured":"Koneczny I (2018) A new classification system for IgG4 autoantibodies. Front Immunol 9:97. https:\/\/doi.org\/10.3389\/fimmu.2018.00097","journal-title":"Front Immunol"},{"key":"12594_CR24","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/acn3.51847","volume":"10","author":"X Kong","year":"2023","unstructured":"Kong X, Gong X, Li A, Liu Y, Li X, Li J, Zhou D, Hong Z (2023) Efficacy of immunotherapy and prognosis in anti-LGI1 encephalitis patients: a meta-analysis. Ann Clin Transl Neurol 10:1578\u20131589. https:\/\/doi.org\/10.1002\/acn3.51847","journal-title":"Ann Clin Transl Neurol"},{"key":"12594_CR25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/bpa.12818","volume":"30","author":"JC Kuehn","year":"2020","unstructured":"Kuehn JC, Scheuerle A, Bauer J, Becker AJ, Wirtz R, Lewerenz J (2020) A 64-year-old patient with a mesiotemporal mass and symptomatic epilepsy. Brain Pathol 30:413\u2013414. https:\/\/doi.org\/10.1111\/bpa.12818","journal-title":"Brain Pathol"},{"key":"12594_CR26","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ana.25421","volume":"85","author":"J-A Lim","year":"2019","unstructured":"Lim J-A, Lee S-T, Moon J, Jun J-S, Kim T-J, Shin Y-W, Abdullah S, Byun J-I, Sunwoo J-S, Kim KT, Yang T-W, Lee W-J, Moon H-J, Kim DW, Lim BC, Cho YW, Yang T-H, Kim HJ, Kim Y-S, Koo YS, Park B, Jung K-H, Kim M, Park K-I, Jung K-Y, Chu K, Lee SK (2019) Development of the clinical assessment scale in autoimmune encephalitis. Ann Neurol 85:352\u2013358. https:\/\/doi.org\/10.1002\/ana.25421","journal-title":"Ann Neurol"},{"key":"12594_CR27","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00415-014-7408-6","volume":"261","author":"MP Malter","year":"2014","unstructured":"Malter MP, Frisch C, Schoene-Bake JC, Helmstaedter C, Wandinger KP, Stoecker W, Urbach H, Surges R, Elger CE, Vincent AV, Bien CG (2014) Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity. J Neurol 261:1695\u20131705. https:\/\/doi.org\/10.1007\/s00415-014-7408-6","journal-title":"J Neurol"},{"key":"12594_CR28","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000404","volume":"4","author":"L McCracken","year":"2017","unstructured":"McCracken L, Zhang J, Greene M, Crivaro A, Gonzalez J, Kamoun M, Lancaster E (2017) Improving the antibody-based evaluation of autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm 4:e404. https:\/\/doi.org\/10.1212\/NXI.0000000000000404","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"12594_CR29","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1093\/arclin\/acac001","volume":"37","author":"C Mueller","year":"2022","unstructured":"Mueller C, Langenbruch L, Rau JMH, Brix T, Strippel C, Dik A, Golombeck KS, M\u00f6nig C, Johnen A, R\u00e4uber S, Wiendl H, Meuth SG, B\u00f6lte J, Kovac S, Melzer N (2022) Neuropsychological performance in autoimmune limbic encephalitis: evidence from an immunotherapy-na\u00efve cohort. Arch Clin Neuropsychol 37:738\u2013752. https:\/\/doi.org\/10.1093\/arclin\/acac001","journal-title":"Arch Clin Neuropsychol"},{"key":"12594_CR30","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1002\/hipo.23375","volume":"31","author":"C Mueller","year":"2021","unstructured":"Mueller C, Langenbruch LM, Rau JMH, Brix T, Strippel C, Dik A, Golombeck KS, Moenig C, Raeuber SJ, Kovac S, Wiendl H, Meuth SG, B\u00f6lte J, Johnen A, Melzer N (2021) Determinants of cognition in autoimmune limbic encephalitis\u2014a retrospective cohort study. Hippocampus 31:1092\u20131103. https:\/\/doi.org\/10.1002\/hipo.23375","journal-title":"Hippocampus"},{"key":"12594_CR31","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000000974","volume":"8","author":"S Mu\u00f1iz-Castrillo","year":"2021","unstructured":"Mu\u00f1iz-Castrillo S, Haesebaert J, Thomas L, Vogrig A, Pinto A-L, Picard G, Blanc C, Do L-D, Joubert B, Berzero G, Psimaras D, Alentorn A, Rogemond V, Dubois V, Ambati A, Tamouza R, Mignot E, Honnorat J (2021) Clinical and prognostic value of immunogenetic characteristics in anti-LGI1 encephalitis. Neurol Neuroimmunol Neuroinflamm 8:e974. https:\/\/doi.org\/10.1212\/nxi.0000000000000974","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"12594_CR32","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/s1474-4422(23)00463-5","volume":"23","author":"A Mu\u00f1oz-Lopetegi","year":"2024","unstructured":"Mu\u00f1oz-Lopetegi A, Guasp M, Prades L, Mart\u00ednez-Hern\u00e1ndez E, Rosa-Just\u00edcia M, Patricio V, Armangu\u00e9 T, Rami L, Borr\u00e0s R, Castro-Fornieles J, Compte A, Gaig C, Santamaria J, Dalmau J (2024) Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study. Lancet Neurol 23:256\u2013266. https:\/\/doi.org\/10.1016\/s1474-4422(23)00463-5","journal-title":"Lancet Neurol"},{"key":"12594_CR33","doi-asserted-by":"publisher","first-page":"1069368","DOI":"10.3389\/fimmu.2022.1069368","volume":"13","author":"G Mu\u00f1oz-S\u00e1nchez","year":"2022","unstructured":"Mu\u00f1oz-S\u00e1nchez G, Planagum\u00e0 J, Naranjo L, Couso R, Sabater L, Guasp M, Mart\u00ednez-Hern\u00e1ndez E, Graus F, Dalmau J, Ruiz-Garc\u00eda R (2022) The diagnosis of anti-LGI1 encephalitis varies with the type of immunodetection assay and sample examined. Front Immunol 13:1069368. https:\/\/doi.org\/10.3389\/fimmu.2022.1069368","journal-title":"Front Immunol"},{"key":"12594_CR34","doi-asserted-by":"publisher","first-page":"18161","DOI":"10.1523\/JNEUROSCI.3506-13.2013","volume":"33","author":"T Ohkawa","year":"2013","unstructured":"Ohkawa T, Fukata Y, Yamasaki M, Miyazaki T, Yokoi N, Takashima H, Watanabe M, Watanabe O, Fukata M (2013) Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci 33:18161\u201318174. https:\/\/doi.org\/10.1523\/JNEUROSCI.3506-13.2013","journal-title":"J Neurosci"},{"key":"12594_CR35","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1093\/brain\/awy253","volume":"141","author":"M Petit-Pedrol","year":"2018","unstructured":"Petit-Pedrol M, Sell J, Planaguma J, Mannara F, Radosevic M, Haselmann H, Ceanga M, Sabater L, Spatola M, Soto D, Gasull X, Dalmau J, Geis C (2018) LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory. Brain 141:3144\u20133159. https:\/\/doi.org\/10.1093\/brain\/awy253","journal-title":"Brain"},{"key":"12594_CR36","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1111\/epi.17699","volume":"64","author":"A Rada","year":"2023","unstructured":"Rada A, Bien CG (2023) What is autoimmune encephalitis-associated epilepsy? Proposal of a practical definition. Epilepsia 64:2249\u20132255. https:\/\/doi.org\/10.1111\/epi.17699","journal-title":"Epilepsia"},{"key":"12594_CR37","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s00415-020-10250-6","volume":"268","author":"A Rada","year":"2021","unstructured":"Rada A, Birnbacher R, Gobbi C, Kurthen M, Ludolph A, Naumann M, Neirich U, von Oertzen TJ, Ransmayr G, Riepe M, Schimmel M, Schwartz O, Surges R, Bien CG (2021) Seizures associated with antibodies against cell surface antigens are acute symptomatic and not indicative of epilepsy: insights from long-term data. J Neurol 268:1059\u20131069. https:\/\/doi.org\/10.1007\/s00415-020-10250-6","journal-title":"J Neurol"},{"key":"12594_CR38","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/brain\/awaa104","volume":"143","author":"M Ramberger","year":"2020","unstructured":"Ramberger M, Berretta A, Tan JMM, Sun B, Michael S, Yeo T, Theorell J, Bashford-Rogers R, Paneva S, O\u2019Dowd V, Dedi N, Topia S, Griffin R, Ramirez-Franco J, El Far O, Baulac S, Leite MI, Sen A, Jeans A, McMillan D, Marshall D, Anthony D, Lightwood D, Waters P, Irani SR (2020) Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms. Brain 143:1731\u20131745. https:\/\/doi.org\/10.1093\/brain\/awaa104","journal-title":"Brain"},{"key":"12594_CR39","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1093\/clinchem\/37.7.1153","volume":"37","author":"H Reiber","year":"1991","unstructured":"Reiber H, Lange P (1991) Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 37:1153\u20131160","journal-title":"Clin Chem"},{"key":"12594_CR40","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1007\/s00415-012-6559-6","volume":"259","author":"J Schultze-Amberger","year":"2012","unstructured":"Schultze-Amberger J, Pehl D, Stenzel W (2012) LGI-1-positive limbic encephalitis: a clinicopathological study. J Neurol 259:2478\u20132480. https:\/\/doi.org\/10.1007\/s00415-012-6559-6","journal-title":"J Neurol"},{"key":"12594_CR41","doi-asserted-by":"publisher","first-page":"5175","DOI":"10.1021\/bi00668a035","volume":"15","author":"VN Schumaker","year":"1976","unstructured":"Schumaker VN, Calcott MA, Spiegelberg HL, Mueller-Eberhard HJ (1976) Ultracentrifuge studies of the binding of IgG of different subclasses to the Clq subunit of the first component of complement. Biochemistry 15:5175\u20135181","journal-title":"Biochemistry"},{"key":"12594_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.618109","volume":"11","author":"X Shao","year":"2021","unstructured":"Shao X, Fan S, Luo H, Wong TY, Zhang W, Guan H, Qiu A (2021) Brain magnetic resonance imaging characteristics of anti-leucine-rich glioma-inactivated 1 encephalitis and their clinical relevance: a single-center study in China. Front Neurol 11:618109. https:\/\/doi.org\/10.3389\/fneur.2020.618109","journal-title":"Front Neurol"},{"key":"12594_CR43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jneuroim.2013.10.005","volume":"265","author":"Y-W Shin","year":"2013","unstructured":"Shin Y-W, Lee S-T, Shin J-W, Moon J, Lim J-A, Byun J-I, Kim T-J, Lee K-J, Kim Y-S, Park K-I, Jung K-H, Lee SK, Chu K (2013) VGKC-complex\/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy. J Neuroimmunol 265:75\u201381. https:\/\/doi.org\/10.1016\/j.jneuroim.2013.10.005","journal-title":"J Neuroimmunol"},{"key":"12594_CR44","doi-asserted-by":"publisher","first-page":"e1141","DOI":"10.1212\/WNL.0000000000012465","volume":"97","author":"KM Smith","year":"2021","unstructured":"Smith KM, Dubey D, Liebo GB, Flanagan EP, Britton JW (2021) Clinical course and features of seizures associated with LGI1-antibody encephalitis. Neurology 97:e1141\u2013e1149. https:\/\/doi.org\/10.1212\/WNL.0000000000012465","journal-title":"Neurology"},{"key":"12594_CR45","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/brain\/awx323","volume":"141","author":"J Thompson","year":"2018","unstructured":"Thompson J, Bi M, Murchison AG, Makuch M, Bien CG, Chu K, Farooque P, Gelfand JM, Geschwind MD, Hirsch LJ, Somerville E, Lang B, Vincent A, Leite MI, Waters P, Irani SR, Faciobrachial Dystonic Seizures Study Group (2018) The importance of early immunotherapy in patients with faciobrachial dystonic seizures. Brain 141:348\u2013356. https:\/\/doi.org\/10.1093\/brain\/awx323","journal-title":"Brain"},{"key":"12594_CR46","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3389\/fimmu.2017.01364","volume":"8","author":"AR Tr\u00f6scher","year":"2017","unstructured":"Tr\u00f6scher AR, Klang A, French M, Quemada-Garrido L, Kneissl SM, Bien CG, P\u00e1kozdy \u00c1, Bauer J (2017) Selective limbic blood\u2013brain barrier breakdown in a feline model of limbic encephalitis with LGI1 antibodies. Front Immunol 8:1364. https:\/\/doi.org\/10.3389\/fimmu.2017.01364","journal-title":"Front Immunol"},{"key":"12594_CR47","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","volume":"87","author":"A van Sonderen","year":"2016","unstructured":"van Sonderen A, Thijs RD, Coenders EC, Jiskoot LC, Sanchez E, de Bruijn MA, van Coevorden-Hameete MH, Wirtz PW, Schreurs MW, Sillevis Smitt PA, Titulaer MJ (2016) Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology 87:1449\u20131456. https:\/\/doi.org\/10.1212\/WNL.0000000000003173","journal-title":"Neurology"},{"key":"12594_CR48","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.0013-9580.2004.09004.x","volume":"45","author":"HG Wieser","year":"2004","unstructured":"Wieser HG, ILAE commission on neurosurgery for epilepsy (2004) ILAE commission report: mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia 45:695\u2013714. https:\/\/doi.org\/10.1111\/j.0013-9580.2004.09004.x","journal-title":"Epilepsia"},{"key":"12594_CR49","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/hipo.22238","volume":"24","author":"JA Witt","year":"2014","unstructured":"Witt JA, Coras R, Schramm J, Becker AJ, Elger CE, Blumcke I, Helmstaedter C (2014) The overall pathological status of the left hippocampus determines preoperative verbal memory performance in left mesial temporal lobe epilepsy. Hippocampus 24:446\u2013454. https:\/\/doi.org\/10.1002\/hipo.22238","journal-title":"Hippocampus"},{"key":"12594_CR50","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3390\/brainsci11050576","volume":"11","author":"JA Witt","year":"2021","unstructured":"Witt JA, Helmstaedter C (2021) Neuropsychological evaluations in limbic encephalitis. Brain Sci 11:576. https:\/\/doi.org\/10.3390\/brainsci11050576","journal-title":"Brain Sci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12594-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12594-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12594-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T08:26:06Z","timestamp":1725524766000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12594-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["12594"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12594-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,6]]},"assertion":[{"value":"2 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors report a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The ethics committee of the Medical Faculty of the University of M\u00fcnster, which is in charge for us, has approved this study and waived patient consent because of the mainly retrospective nature of this work on patients personally investigated and treated by the authors (no. 2020-244-f-S). Nevertheless, 16\/20 patients who were seen prospectively for follow-up in addition signed a consent form. All investigations have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}